Following on from the publication of exciting data from a phase 2 trial last year, NICE has now approved use of olaratumab in combination with doxorubicin for advanced soft tissue sarcoma (STS) in the first-line setting. Doxorubicin has been the backbone of first line chemotherapy for STS for over 30 years and the early data […]
Consider signing up for Soft-Tissue-Sarcoma-a-Clinical-Update-2017 on the 26th September, hosted by the Royal Marsden Hospital.
Prof. Ian Judson has led authorship of the UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST) which have just been published, joining the guidelines for soft tissue, and bone sarcoma published last year. These should provide a valuable resource for sarcoma services nationally to ensure consistent and evidence-based practice.
Over 250 members attended the 13th annual conference, this year hosted in Bristol. The conference goes from strength to strength and we thank all those who submitted posters, or attended this valuable meeting. There were a wide variety of sessions by invited speakers covering subjects including the management of neurofibromatosis, the latest data concerning neoadjuvant chemotherapy […]
Oral Presentation Winner: Leo Feinberg Surgical Management within a Tertiary Referral Service Leads to Improved Disease Specific Survival of Patients with Radiation-associated Angiosarcoma of the Breast 1st Poster Prize: Mariona Chicón Bosch Cancer stem-like cells isolated from Ewing’s sarcoma samples provide unique insight into tumour heterogeneity 2nd Poster Prize (two 2nd prize poster winners): […]
Best Young Researcher 2016: George Watkinson Two presentations: Post-operative nomogram for retroperitoneal sarcoma is able to accurately predict three and five year survival of patients in the retrospective Northern RPS database George Watkinson Synergistic Activity with combination of MDM2-p53 inhibition and ionising radiation in retroperitoneal […]